Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03122457Phase 2Completed
Phase 2, open-label, single-arm trial of clindamycin and benzoyl peroxide in acne vulgaris, sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Physician Global Assessment at Day 99. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03122457.